MedPath

Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach

Phase 3
Conditions
Gastric Cancer
Registration Number
NCT00003617
Lead Sponsor
Lymphoma Trials Office
Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. It is not yet known whether chlorambucil is more effective than observation in treating low-grade lymphoma of the stomach.

PURPOSE: Randomized phase III trial to compare the effectiveness of chlorambucil with that of no further therapy following anti-Helicobacter therapy in treating patients with low-grade lymphoma of the stomach.

Detailed Description

OBJECTIVES: I. Determine the efficacy and response rate of triple antibiotic therapy for Helicobacter pylori in the healing of lesions in patients with low grade gastric lymphoma. II. Assess the efficacy of chlorambucil in the prevention of relapse in patients after complete eradication of low grade gastric lymphoma. III. Determine the natural history of unresected or partially resected low grade gastric lymphoma treated medically.

OUTLINE: This is a randomized study. Patients are randomized to receive chlorambucil or placebo. Patients receive omeprazole daily for 1 week. Clarithromycin and tinidazole are administered twice daily for 1 week for the eradication of H. pylori infection. Patients are assessed every 2-3 months by endoscopy. Patients may receive a maximum of 3 courses of treatment every 2-3 months. Other regimens may be used if full eradication of H. pylori is not achieved. Patients who achieve complete response (eradication of H. pylori) are randomized to receive oral chlorambucil or placebo daily for 14 days. Treatment is repeated every 28 days for 6 courses. Patients are followed every 6 months for 2 years, then yearly thereafter.

PROJECTED ACCRUAL: A total of 200 patients will be accrued for this study.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (30)

Clatterbridge Centre for Oncology NHS Trust

πŸ‡¬πŸ‡§

Merseyside, England, United Kingdom

Leeds Teaching Hospital Trust

πŸ‡¬πŸ‡§

Leeds, England, United Kingdom

Essex County Hospital

πŸ‡¬πŸ‡§

Colchester, England, United Kingdom

Ipswich Hospital NHS Trust

πŸ‡¬πŸ‡§

Ipswich, England, United Kingdom

Nottingham City Hospital NHS Trust

πŸ‡¬πŸ‡§

Nottingham, England, United Kingdom

Peterborough Hospitals Trust

πŸ‡¬πŸ‡§

Peterborough, England, United Kingdom

Good Hope Hospital Trust

πŸ‡¬πŸ‡§

West Midlands, England, United Kingdom

Weston Park Hospital

πŸ‡¬πŸ‡§

Sheffield, England, United Kingdom

Southend NHS Trust Hospital

πŸ‡¬πŸ‡§

Westcliff-On-Sea, England, United Kingdom

James Paget Hospital

πŸ‡¬πŸ‡§

Norfolk, United Kingdom

Rotherham District General Hospital-NHS Trust

πŸ‡¬πŸ‡§

Rotherham, United Kingdom

Frere Hospital

πŸ‡ΏπŸ‡¦

Central Region, South Africa

Oncology Centre Institute

πŸ‡΅πŸ‡±

Warsaw, Poland

Kent and Canterbury Hospital

πŸ‡¬πŸ‡§

Canterbury, England, United Kingdom

Salisbury District Hospital

πŸ‡¬πŸ‡§

Salisbury, United Kingdom

Stoke Mandeville Hospital

πŸ‡¬πŸ‡§

Aylesbury-Buckinghamshire, England, United Kingdom

Royal Free Hospital

πŸ‡¬πŸ‡§

Hampstead, London, England, United Kingdom

Kettering General Hosptial

πŸ‡¬πŸ‡§

Kettering, Northants, United Kingdom

Staffordshire General Hospital

πŸ‡¬πŸ‡§

Stafford, United Kingdom

Bradford Hospitals NHS Trust

πŸ‡¬πŸ‡§

Bradford, England, United Kingdom

Walsgrave Hospital

πŸ‡¬πŸ‡§

Coventry, England, United Kingdom

Ospedale San Giovanni

πŸ‡¨πŸ‡­

Bellinzona, Switzerland

Milton Keynes General Hospital

πŸ‡¬πŸ‡§

Milton Keynes, England, United Kingdom

Middlesex Hospital- Meyerstein Institute

πŸ‡¬πŸ‡§

London, England, United Kingdom

Mount Vernon Hospital

πŸ‡¬πŸ‡§

Northwood, England, United Kingdom

Salford Royal Hospitals NHS Trust

πŸ‡¬πŸ‡§

Salford, England, United Kingdom

Royal Marsden Hospital

πŸ‡¬πŸ‡§

Sutton, England, United Kingdom

York District Hospital

πŸ‡¬πŸ‡§

York, England, United Kingdom

Charing Cross Hospital

πŸ‡¬πŸ‡§

London, England, United Kingdom

Queen Mary Hospital

πŸ‡­πŸ‡°

Hong Kong, Hong Kong

Β© Copyright 2025. All Rights Reserved by MedPath